Ge Lou Selected Research

Ge Lou Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 01/2008
38	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 04/2009
20	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 01/2011
18	Ovarian Epithelial Carcinoma 01/2022 - 08/2005
17	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2011
15	Carcinoma (Carcinomatosis) 01/2022 - 08/2005
10	Lymphatic Metastasis 01/2021 - 01/2008
9	Carcinogenesis 01/2021 - 07/2010
6	Disease Progression 12/2022 - 01/2017
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 07/2010
3	Residual Neoplasm 01/2020 - 06/2014
3	Breast Neoplasms (Breast Cancer) 09/2017 - 01/2008
3	Stomach Neoplasms (Stomach Cancer) 03/2015 - 08/2005
2	Nausea 12/2022 - 01/2021
2	Anemia 12/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2014
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2021
1	Glioma (Gliomas) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Leukopenia 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Serous Cystadenocarcinoma 01/2020
1	Peritoneal Neoplasms 05/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2017
1	Leiomyoma (Uterine Fibroids) 04/2016
1	Uterine Cervical Dysplasia 04/2016
1	Adenocarcinoma 01/2016

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2009
23	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2008
12	PlatinumIBA 12/2022 - 06/2014
11	Long Noncoding RNAIBA 01/2022 - 09/2015
8	Messenger RNA (mRNA)IBA 01/2021 - 01/2008
7	Biological ProductsIBA 01/2022 - 01/2016
7	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 08/2005
4	Pharmaceutical PreparationsIBA 12/2021 - 04/2009
4	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 12/2016
3	olaparibIBA 12/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 07/2020
2	fluzoparibIBA 01/2022 - 01/2021
2	Antisense RNA (Anti-Sense RNA)IBA 01/2021 - 01/2019
2	serum P-component (CIt)IBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2011
2	Circular RNAIBA 01/2021 - 12/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2017
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2014
2	Platelet-Derived Growth FactorIBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2014
2	CytokinesIBA 09/2017 - 04/2015
2	CollagenIBA 01/2017 - 05/2014
2	Estrogens (Estrogen)FDA Link 01/2015 - 01/2008
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2015 - 08/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014 - 06/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 02/2012
2	Oncogene Proteins (Oncogene Protein)IBA 06/2011 - 07/2010
1	Poly Adenosine Diphosphate RiboseIBA 12/2022
1	pamiparibIBA 01/2022
1	camrelizumabIBA 01/2022
1	famitinibIBA 01/2022
1	FurinIBA 11/2021
1	VimentinIBA 01/2021
1	DesminIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	ELAV-Like Protein 1IBA 01/2021
1	E2F2 Transcription FactorIBA 01/2021
1	Competitive Endogenous RNAIBA 11/2020
1	niraparibIBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	E2F Transcription FactorsIBA 01/2020
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2020
1	Ellagic AcidIBA 07/2018
1	Inositol (Myoinositol)IBA 06/2018
1	GTP Phosphohydrolases (GTPases)IBA 05/2018
1	interferon regulatory factor-4IBA 05/2018
1	S100 Calcium Binding Protein A7IBA 05/2018
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 05/2018
1	Carrier Proteins (Binding Protein)IBA 05/2018
1	LuciferasesIBA 03/2018
1	sonidegibIBA 01/2018
1	Therapeutic UsesIBA 09/2017
1	1,1-dimethyl-4-acetylpiperaziniumIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 11/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2016
1	IntegrinsIBA 11/2016
1	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 04/2016

Therapy/Procedure

15	Therapeutics 01/2022 - 10/2013
12	Drug Therapy (Chemotherapy) 01/2022 - 07/2011
6	Immunotherapy 01/2021 - 01/2018
4	Neoadjuvant Therapy 01/2017 - 01/2011
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2011
2	Radiotherapy 01/2019 - 01/2013
1	Precision Medicine 01/2018